Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $135.45 million. The enterprise value is -$14.16 million.
Important Dates
The last earnings date was Monday, August 4, 2025, after market close.
| Earnings Date | Aug 4, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medifast has 10.27 million shares outstanding. The number of shares has increased by 0.54% in one year.
| Current Share Class | 10.27M |
| Shares Outstanding | 10.27M |
| Shares Change (YoY) | +0.54% |
| Shares Change (QoQ) | +1.02% |
| Owned by Insiders (%) | 3.01% |
| Owned by Institutions (%) | 73.76% |
| Float | 9.07M |
Valuation Ratios
The trailing PE ratio is 39.98.
| PE Ratio | 39.98 |
| Forward PE | n/a |
| PS Ratio | 0.30 |
| Forward PS | 0.35 |
| PB Ratio | 0.63 |
| P/TBV Ratio | 0.63 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 32.61 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.47, with a Debt / Equity ratio of 0.06.
| Current Ratio | 4.47 |
| Quick Ratio | 3.52 |
| Debt / Equity | 0.06 |
| Debt / EBITDA | 0.41 |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.73% and return on invested capital (ROIC) is 3.58%.
| Return on Equity (ROE) | 1.73% |
| Return on Assets (ROA) | 2.88% |
| Return on Invested Capital (ROIC) | 3.58% |
| Return on Capital Employed (ROCE) | 5.82% |
| Revenue Per Employee | $953,272 |
| Profits Per Employee | $7,214 |
| Employee Count | 504 |
| Asset Turnover | 1.71 |
| Inventory Turnover | 3.60 |
Taxes
In the past 12 months, Medifast has paid $2.62 million in taxes.
| Income Tax | 2.62M |
| Effective Tax Rate | 41.84% |
Stock Price Statistics
The stock price has decreased by -32.46% in the last 52 weeks. The beta is 0.82, so Medifast's price volatility has been lower than the market average.
| Beta (5Y) | 0.82 |
| 52-Week Price Change | -32.46% |
| 50-Day Moving Average | 13.79 |
| 200-Day Moving Average | 15.18 |
| Relative Strength Index (RSI) | 42.94 |
| Average Volume (20 Days) | 221,754 |
Short Selling Information
The latest short interest is 2.29 million, so 22.30% of the outstanding shares have been sold short.
| Short Interest | 2.29M |
| Short Previous Month | 1.88M |
| Short % of Shares Out | 22.30% |
| Short % of Float | 25.24% |
| Short Ratio (days to cover) | 11.35 |
Income Statement
In the last 12 months, Medifast had revenue of $480.45 million and earned $3.64 million in profits. Earnings per share was $0.33.
| Revenue | 480.45M |
| Gross Profit | 354.78M |
| Operating Income | 12.99M |
| Pretax Income | 37.29M |
| Net Income | 3.64M |
| EBITDA | 26.69M |
| EBIT | 12.99M |
| Earnings Per Share (EPS) | $0.33 |
Full Income StatementBalance Sheet
The company has $162.67 million in cash and $13.07 million in debt, giving a net cash position of $149.61 million or $14.57 per share.
| Cash & Cash Equivalents | 162.67M |
| Total Debt | 13.07M |
| Net Cash | 149.61M |
| Net Cash Per Share | $14.57 |
| Equity (Book Value) | 216.01M |
| Book Value Per Share | 21.03 |
| Working Capital | 160.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $4.15 million and capital expenditures -$6.58 million, giving a free cash flow of -$2.42 million.
| Operating Cash Flow | 4.15M |
| Capital Expenditures | -6.58M |
| Free Cash Flow | -2.42M |
| FCF Per Share | -$0.24 |
Full Cash Flow StatementMargins
Gross margin is 73.84%, with operating and profit margins of 2.70% and 0.76%.
| Gross Margin | 73.84% |
| Operating Margin | 2.70% |
| Pretax Margin | 1.30% |
| Profit Margin | 0.76% |
| EBITDA Margin | 5.56% |
| EBIT Margin | 2.70% |
| FCF Margin | n/a |
Dividends & Yields
Medifast does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.54% |
| Shareholder Yield | -0.54% |
| Earnings Yield | 2.68% |
| FCF Yield | -1.79% |
Dividend DetailsAnalyst Forecast
The average price target for Medifast is $16.50, which is 25.10% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.50 |
| Price Target Difference | 25.10% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 5.56 and a Piotroski F-Score of 5.
| Altman Z-Score | 5.56 |
| Piotroski F-Score | 5 |
